Amalgamated Bank Ironwood Pharmaceuticals Inc Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Amalgamated Bank holds 41,457 shares of IRWD stock, worth $146,343. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,457

Previous 41,744 0.69%

Holding current value

$146,343

Previous $272,000 37.13%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$3.93 - $7.04 $1,127 - $2,020	-287 Reduced 0.69%	41,457 $171,000
Q2 2024 Aug 12, 2024	SELL	$5.58 - $8.61 $8,174 - $12,613	-1,465 Reduced 3.39%	41,744 $272,000
Q1 2024 Apr 23, 2024	SELL	$8.32 - $15.45 $87,859 - $163,152	-10,560 Reduced 19.64%	43,209 $376,000
Q4 2023 Feb 06, 2024	SELL	$8.79 - $11.51 $33,700 - $44,129	-3,834 Reduced 6.66%	53,769 $615,000
Q2 2023 Aug 11, 2023	SELL	$10.1 - $11.6 $39,359 - $45,205	-3,897 Reduced 6.34%	57,603 $612,000
Q1 2023 May 02, 2023	SELL	$10.37 - $12.56 $43,149 - $52,262	-4,161 Reduced 6.34%	61,500 $647,000
Q3 2022 Nov 09, 2022	SELL	$10.14 - $12.38 $61,164 - $74,676	-6,032 Reduced 8.41%	65,661 $680,000
Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $527,714 - $607,469	47,757 Added 199.52%	71,693 $827,000
Q1 2022 Jun 30, 2022	SELL	$10.61 - $12.88 $19,257 - $23,377	-1,815 Reduced 7.05%	23,936 $301,000
Q4 2021 Feb 15, 2022	SELL	$10.86 - $13.95 $999 - $1,283	-92 Reduced 0.36%	25,751 $300,000
Q3 2021 Oct 29, 2021	SELL	$11.92 - $13.92 $18,964 - $22,146	-1,591 Reduced 5.8%	25,843 $338,000
Q2 2021 Aug 16, 2021	BUY	$10.16 - $13.11 $48,341 - $62,377	4,758 Added 20.98%	27,434 $353,000
Q1 2021 May 13, 2021	SELL	$9.04 - $11.86 $20,412 - $26,779	-2,258 Reduced 9.06%	22,676 $254,000
Q4 2020 Feb 12, 2021	BUY	$9.05 - $12.2 $1,167 - $1,573	129 Added 0.52%	24,934 $283,000
Q3 2020 Oct 30, 2020	SELL	$8.99 - $10.74 $6,427 - $7,679	-715 Reduced 2.8%	24,805 $223,000
Q2 2020 Aug 10, 2020	SELL	$9.14 - $11.97 $18,609 - $24,370	-2,036 Reduced 7.39%	25,520 $263,000
Q1 2020 May 13, 2020	SELL	$8.58 - $14.01 $2,771 - $4,525	-323 Reduced 1.16%	27,556 $278,000
Q4 2019 Feb 13, 2020	BUY	$8.22 - $14.0 $4,907 - $8,358	597 Added 2.19%	27,879 $371,000
Q3 2019 Nov 13, 2019	SELL	$8.59 - $10.96 $3,478 - $4,438	-405 Reduced 1.46%	27,282 $234,000
Q2 2019 Aug 14, 2019	BUY	$9.8 - $12.89 $62,759 - $82,547	6,404 Added 30.09%	27,687 $303,000
Q1 2019 May 15, 2019	BUY	$8.27 - $12.73 $7,269 - $11,189	879 Added 4.31%	21,283 $288,000
Q4 2018 Feb 15, 2019	BUY	$7.8 - $16.13 $159,151 - $329,116	20,404 New	20,404 $211,000
Q3 2018 Nov 14, 2018	SELL	$14.31 - $17.65 $302,742 - $373,403	-21,156 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$11.83 - $16.2 $37,169 - $50,900	3,142 Added 17.44%	21,156 $405,000
Q1 2018 May 22, 2018	SELL	$11.13 - $13.63 $2,938 - $3,598	-264 Reduced 1.44%	18,014 $278,000
Q4 2017 Feb 13, 2018	BUY	$12.16 - $14.58 $13,825 - $16,577	1,137 Added 6.63%	18,278 $274,000
Q3 2017 Nov 09, 2017	BUY	$12.07 - $14.87 $206,891 - $254,886	17,141	17,141 $270,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Ironwood Pharmaceuticals Inc Transaction History